Senescent-like macrophages mediate angiogenesis for endplate sclerosis via IL-10 secretion in male mice

Yonggang Fan1, Weixin Zhang2, Xiusheng Huang1

  • 1Department of Orthopaedics, 1st Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, PR China.

Nature Communications
|April 5, 2024
PubMed

Insights

Senescent macrophages drive spine degeneration by promoting angiogenesis and sclerosis via IL-10. Blocking p16 in macrophages prevents these changes, offering therapeutic insights for endplate sclerosis.

Area of Science:

  • Immunology
  • Gerontology
  • Orthopedics

Background:

  • Endplate sclerosis is a common feature of spinal degeneration and aging.
  • The underlying mechanisms of endplate sclerosis are not fully understood.

Purpose of the Study:

  • To investigate the role of senescent macrophages in endplate sclerosis.
  • To elucidate the molecular mechanisms linking immune senescence to spinal degeneration.

Main Methods:

  • Utilized a male mouse model of lumbar spine instability (LSI) or aging.
  • Generated macrophage-specific cdkn2a (p16) knockout mice.
  • Performed in vivo and in vitro studies to analyze cytokine profiles and cellular signaling pathways.

Main Results:

  • Senescent macrophages accumulate in sclerotic endplates of aging/LSI mice.
  • Macrophage p16 knockout inhibited LSI/aging-induced angiogenesis and sclerosis.
  • Interleukin-10 (IL-10) was identified as a key elevated cytokine in senescence-related secretory phenotype (SASP).
  • IL-10 signaling via pSTAT3 in endothelial cells promoted the expression of Vegfa, Mmp2, and Pdgfb, driving angiogenesis.

Conclusions:

  • Immune senescence, specifically via macrophages, contributes to endplate sclerosis.
  • The IL-10/pSTAT3/VEGF pathway is crucial for angiogenesis in endplate degeneration.
  • Targeting macrophage senescence may offer novel therapeutic strategies for endplate sclerosis.

Related Concept Videos